Table 1: Patient characteristics at the time of transfer.

Patient Characteristics Subjects (n=39)
Age, years 29.0 ± 9.3 (18–57)
Male, n (%) 25/39 (64)
Genotype
  Δ F508 homozygous, n (%) 22 (56)
  Δ F508 heterozygous, n (%) 14 (36)
  Other, n (%) 3 (8)
BMI, kg/m2 20.9 ± 3.2 (16.8–30.1)
FEV1, L 2.2 ± 1.1 (0.82–4.49)
FEV1, % predicted 57.7 ± 27.0 (24–120)
FVC, L 3.2 ± 1.3 (1.05–5.53)
FVC, % predicted 71.1 ± 25.6 (29–135)
Pancreatic insufficiency, n (%) 35/39 (90)
Pseudomonas aeruginosa positive, n (%) 21/39 (54)
Cystic fibrosis-related diabetes, n (%) 11/39 (28)

Results are presented as mean ± standard deviation (range), or number of patients (%).
BMI, Body Mass Index; FEV1, Forced Expiratory Volume in 1 second; FVC, Forced Vital Capacity.